Streetwise Reports' Article Archives — Current Month (1)

Wedbush Sees Denifanstat as Front-Line Acne Therapy with 249% Upside Potential (05/01/2026)

Wedbush Securities analyst Dr. Yun Zhong reiterated a price target on Sagimet Biosciences (SGMT:NASDAQ), implying roughly 249% upside.

more>

More Archives

2026Apr Mar Feb Jan

2025Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2024Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2023Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2022Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2021Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec